Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
The New York Times has filed a lawsuit against Microsoft and Open AI, accusing both of infringing copyright and abusing the intellectual property of the newspaper.
